Trump Administered COVID-19 Treatment Tested In Chattanooga

After testing positive for COVID-19, President Trump has received several experimental treatments to combat the illness at Walter Reed National Military Medical Center.

One such treatment is an investigational antibody drug therapy, developed by pharmaceutical company, Regeneron.

This drug is currently being tried by independent clinical research center, ClinSearch on Shallowford Road in Chattanooga.

ClinSearch currently is enrolling participants for a wide array of studies including COVID-19, Celiac Disease, Crohn’s Disease, Parkinson’s Disease and many more.

The President was given a single dose of the experimental antibody cocktail along with several other drugs and supplements, including zinc, vitamin D, and the generic version of the heartburn treatement Pepcid according to a letter from his doctor that was released from the White House.

In the letter, the President’s doctor, Sean Conley said “he completed the infusion without incident and he remains fatigued but in good spirits“.

President Trump and First Lady, Melania Trump, announced Friday morning that they had tested positive for COVID-10.

According to a report by CNN, President Trump’s symptoms were far worse than the First Lady’s and he was considered at higher risk because of his age.

As reported by The New York Times, there are no approved treatments for Covid-19, but the Regeneron treatment is one of the most promising candidates, along with another antibody treatment developed by Eli Lilly. Both are being tested in patients around the country.

Initial results have suggested that they can reduce the level of the virus in the body and possibly shorten hospital stays — when they are given early in the course of infection.

Until the FDA approves the treatment, it will not be made available to the public.

With the increased interest generated by the drug’s use on the President, Dr. Mark McKenzie of ClinSearch stated that he hopes the FDA approval process will progress rapidly.